Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model
Fetal Diagnosis and Therapy · 2024
DOI: 10.1159/000541429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2024. Verfasst von Kamila Moskowitzova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: RNA, Messenger, Pulmonary Surfactant-Associated Protein B, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
We sought to determine whether exogenous surfactant protein B (SPB) mRNA could be incorporated and translated by the fetal lung after simple transamniotic administration.
Methods
Fetuses (n = 149) of twelve time-dated dams underwent intra-amniotic injections of either human SPB (hSPB) mRNA encapsulated into lipopolyplex (mRNA, n = 99) or lipopolyplex without mRNA (control; n = 50) on gestational day 17 (E17, term = E21–22). Lungs were screened for hSPB by enzyme-linked immunosorbent assay daily until term. Phosphatidylcholine (PC) (a surrogate for surfactant production) was measured in the amniotic fluid by fluorometric assay. Statistical analysis included nonparametric Wilcoxon rank sum test.
Results
Significantly improved survival in the mRNA group compared to controls was observed at E18 (100% vs. 85.7%) and E20 (100% vs. 83.3%) (both p < 0.001). When controlled by mRNA-free injections, hSPB protein was detected in the mRNA group’s lungs at E18, 19, and term (p = 0.002 to <0.001). Amniotic fluid PC levels were increased compared to control at term [285.9 (251.1, 363.9) μM versus 263.1 (222.8, 309.1) μM]; however, this did not reach significance (p = 0.33).
Conclusions
Encapsulated exogenous SPB mRNA can be incorporated and translated by fetal lung cells following intra-amniotic injection in a healthy rat model. Transamniotic mRNA delivery could become a novel strategy for perinatal surfactant protein replacement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Zitieren
APA
Moskowitzova, K., Naus, A. E., Dang, T. T., Zurakowski, D., & Fauza, D. O. (2024). Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000541429
Vancouver
Moskowitzova K, Naus AE, Dang TT, Zurakowski D, Fauza DO. Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model. Fetal Diagnosis and Therapy. 2024. doi:10.1159/000541429
BibTeX
@article{Moskowitzova2024,
author = {Moskowitzova, Kamila and Naus, Abbie E and Dang, Tanya T and Zurakowski, David and Fauza, Dario O},
title = {Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model},
journal = {Fetal Diagnosis and Therapy},
year = {2024},
doi = {10.1159/000541429}
}
EUVIMED